P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA

Bibliographic Details
Main Authors: Jochen Greiner, Patrick Schuler, Hubert Schrezenmeier, Susanne Hofmann, Marlies Götz
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000968816.72631.a8
_version_ 1827331811299033088
author Jochen Greiner
Patrick Schuler
Hubert Schrezenmeier
Susanne Hofmann
Marlies Götz
author_facet Jochen Greiner
Patrick Schuler
Hubert Schrezenmeier
Susanne Hofmann
Marlies Götz
author_sort Jochen Greiner
collection DOAJ
first_indexed 2024-03-07T16:46:39Z
format Article
id doaj.art-df5412f6a5fb4e4e9ab8c749e2a25c73
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:46:39Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-df5412f6a5fb4e4e9ab8c749e2a25c732024-03-03T06:26:04ZengWileyHemaSphere2572-92412023-08-017e72631a810.1097/01.HS9.0000968816.72631.a8202308003-00378P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIAJochen Greiner0Patrick Schuler1Hubert Schrezenmeier2Susanne Hofmann3Marlies Götz41 Diakonie Hospital Stuttgart, Department of Internal Medicine, Stuttgart, Germany3 University Hospital Ulm, Department of Otorhinolaryngology, Ulm4 University of Ulm and German Red Cross, Institute of Transfusion Medicine, Ulm, Germany5 University Hospital Heidelberg, Department of Internal Medicine V, Heidelberg, Germany2 University Hospital Ulm, Department of Internal Medicine III, Ulm, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000968816.72631.a8
spellingShingle Jochen Greiner
Patrick Schuler
Hubert Schrezenmeier
Susanne Hofmann
Marlies Götz
P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
HemaSphere
title P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
title_full P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
title_fullStr P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
title_full_unstemmed P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
title_short P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
title_sort p477 combination of different immunotherapeutic drugs enhances specific t cell immune responses against leukemic cells and leukemic progenitor stem cells in acute myeloid leukemia
url http://journals.lww.com/10.1097/01.HS9.0000968816.72631.a8
work_keys_str_mv AT jochengreiner p477combinationofdifferentimmunotherapeuticdrugsenhancesspecifictcellimmuneresponsesagainstleukemiccellsandleukemicprogenitorstemcellsinacutemyeloidleukemia
AT patrickschuler p477combinationofdifferentimmunotherapeuticdrugsenhancesspecifictcellimmuneresponsesagainstleukemiccellsandleukemicprogenitorstemcellsinacutemyeloidleukemia
AT hubertschrezenmeier p477combinationofdifferentimmunotherapeuticdrugsenhancesspecifictcellimmuneresponsesagainstleukemiccellsandleukemicprogenitorstemcellsinacutemyeloidleukemia
AT susannehofmann p477combinationofdifferentimmunotherapeuticdrugsenhancesspecifictcellimmuneresponsesagainstleukemiccellsandleukemicprogenitorstemcellsinacutemyeloidleukemia
AT marliesgotz p477combinationofdifferentimmunotherapeuticdrugsenhancesspecifictcellimmuneresponsesagainstleukemiccellsandleukemicprogenitorstemcellsinacutemyeloidleukemia